Researcher

Riedel, Wim J.

Extraordinary Professor

View graph of relations
  1. 2019
  2. Published
  3. 2017
  4. Published
  5. 2016
  6. Published
  7. 2015
  8. Published
  9. Published
  10. Published
    Riedel, W. J., & Blokland, A. (2015). Declarative memory. In Handbook of Experimental Pharmacology (Vol. 228, pp. 215-36) https://doi.org/10.1007/978-3-319-16522-6_7
  11. 2014
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. 2013
  20. Published
  21. Published
  22. Published
    Riedel, W. (2013). Psychopharmacology of Cognition Enhancement. e6-e6. Abstract from 15th Biennial Meeting of the European Behavioural Pharmacology Society, . https://doi.org/10.1097/01.fbp.0000434702.91636.93
  23. 2012
  24. Published
  25. Published
  26. Published
  27. Published
  28. 2011
  29. Published
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
    van Ruitenbeek, P., Vermeeren, A., Mehta, M., Drexler, E., & Riedel, W. (2011). Specific effects of central h-1 antagonism on sensori-motor performance and bold response. S341-S342. Abstract from 40th Annual Meeting of the European Histamine Research Society, . https://doi.org/10.1007/s00011-011-0371-0
  37. 2010
  38. Published
  39. Published
  40. Published
  41. Published
    Comley, R. A., Miller, S., Murthy, V., Bhagwagar, Z., Turner, D., Peers, P., ... Rabiner, E. (2010). Association between serotonin transporter binding, physiological and environmental factors in healthy male subjects. S93-S94. Poster session presented at The Eighth International Symposium on Functional Neuroreceptor Mapping of the Living Brain — NRM 2010, . https://doi.org/10.1016/j.neuroimage.2010.04.075
  42. Published
  43. Published
  44. Published
  45. Published
  46. 2009
  47. Published
  48. Published
  49. Published
  50. Published
    Covington, M. A., Riedel, W. J., Brown, C., He, C., Morris, E., Weinstein, S., ... Brown, J. (2009). Ketamine and schizophrenic speech: more difference than originally reported. Journal of Psychopharmacology, 23(1), 111-112. https://doi.org/10.1177/0269881108091590
  51. Published
  52. Published
  53. Published
    Pfeifer, S., Schiller, N. O., van Os, J., Riedel, W., & Krabbendam, L. (2009). Semantic priming abnormalities as putative endophenotype of psychosis: an event-related potential study. 248-248. Abstract from 12th International Congress on Schizophrenia Research (ICOSR), . https://doi.org/10.1093/schbul/sbn173
  54. Published
  55. 2008
  56. Published
    Murthy, N. V., Cowen, P. J., Selvaraj, S., Riedel, W. J., Peers, P., Kennedy, J., ... Grasby, P. M. (2008). 5-HTTLPR Polymorphisms (SLC6A4 & rs25531) do not affect 5-HT transporter expression in the living human brain. 231S-232S.
  57. Published
  58. Published
  59. Published
  60. Published
    Simons, C., Sambeth, A. V., van Os, J., Krabbendam, L., & Riedel, W. (2008). P300 and n100 components in schizophrenia patients and their first-degree relatives. 109-109. Abstract from 1st Schizophrenia International Research Society Conference, . https://doi.org/10.1016/S0920-9964(08)70329-3
  61. Published
    Riedel, W. J. (2008). Psychopharmaceutical Cognition Enhancement. In L. Zonneveld, H. Dijstelbloem, & D. Ringoir (Eds.), Reshaping the Human Condition: Exploring Human Enhancement (pp. 115-122). The Hague: Rathenau Institute.
Previous 1 2 Next